Cipla acquires brand, trademark rights for anti-diabetic drug Vysov in India Press Trust of India Dec 17, 2019 Cipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M (Vildagliptin plus…
